FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W162955259> ?p ?o ?g. }

• W162955259 endingPage "3" @default.
• W162955259 startingPage "571" @default.
• W162955259 abstract "Antiphospholipid antibody (APL) is a particularly important laboratory diagnostic criterion for antiphospholipid syndrome (APS). The significances of positive APL in childhood are seldom reported nor fully understood. The purpose of this study was to analyze 13 cases with positive APL seen in our hospital and to study the relationship between the positive rates of APL and various clinical diseases especially systemic lupus erythematosus (SLE) in order to improve the clinical diagnoses and treatment level of APS in children.The clinical data collected from 2000 to 2002 of 13 hospitalized children with positive APL were retrospectively evaluated. Enzyme linked immunosorbent assay (ELISA) and indirect immunofluorescence technique were used respectively to detect APL and antineutrophil cytoplasmic autoantibodies (ANCA) of sera from those children. Other various indexes were also detected according to different characteristics of different diseases.Eight cases had SLE; 2 had acute post-streptococcal infections. The other 3 cases did not show any evidences of primary diseases; they probably had primary APS. SLE was the most common primary diseases to cause development of APL and the cases with SLE showed more severe cutaneous vasculitis than SLE patients who were negative for APL. There was no significant relationship between the positive rates of APL and that of ANCA. Eight APL positive cases complicated with thrombocytopenia and bleeding were treated with high dosage of immunoglobulin [400 mg/(kg.d), for 3 - 5 d] intravenously; the clinical conditions of these cases were ameliorated soon. While the 5 cases who had thrombotic vasculitis and thromboembolism were treated with anticoagulant and antithrombotic therapy with low molecular weight heparin [50 - 100 U/(kg.d)], which led to good clinical effects.The clinical manifestations of children positive for APL were somehow different from those of adults. Positive APL itself may be nonspecific, it can occur from different causes of diseases. APL detection may be useful to suggest anticoagulant and/or antithrombosis therapy. Treatments for APS should be variable according to different causes and severity of diseases, in the cases of thrombocytopenia and bleeding, high dose intravenous immunoglobulin should be given as soon as possible, while in the cases of thrombotic vasculitis and thromboembolism, anticoagulant and antithrombotic therapy should be given soon." @default.
• W162955259 created "2016-06-24" @default.
• W162955259 creator A5021662366 @default.
• W162955259 creator A5041305048 @default.
• W162955259 creator A5057516581 @default.
• W162955259 creator A5071013421 @default.
• W162955259 creator A5081554370 @default.
• W162955259 creator A5086664284 @default.
• W162955259 date "2004-08-01" @default.
• W162955259 modified "2023-09-26" @default.
• W162955259 title "[Clinical significance of antiphospholipid antibody in pediatric patients and review of literature]." @default.
• W162955259 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15347440" @default.
• W162955259 hasPublicationYear "2004" @default.
• W162955259 type Work @default.
• W162955259 sameAs 162955259 @default.
• W162955259 citedByCount "0" @default.
• W162955259 crossrefType "journal-article" @default.
• W162955259 hasAuthorship W162955259A5021662366 @default.
• W162955259 hasAuthorship W162955259A5041305048 @default.
• W162955259 hasAuthorship W162955259A5057516581 @default.
• W162955259 hasAuthorship W162955259A5071013421 @default.
• W162955259 hasAuthorship W162955259A5081554370 @default.
• W162955259 hasAuthorship W162955259A5086664284 @default.
• W162955259 hasConcept C126322002 @default.
• W162955259 hasConcept C159654299 @default.
• W162955259 hasConcept C163764329 @default.
• W162955259 hasConcept C187212893 @default.
• W162955259 hasConcept C203014093 @default.
• W162955259 hasConcept C2776015282 @default.
• W162955259 hasConcept C2776874634 @default.
• W162955259 hasConcept C2777015399 @default.
• W162955259 hasConcept C2779134260 @default.
• W162955259 hasConcept C2780022809 @default.
• W162955259 hasConcept C63363279 @default.
• W162955259 hasConcept C71924100 @default.
• W162955259 hasConcept C90924648 @default.
• W162955259 hasConceptScore W162955259C126322002 @default.
• W162955259 hasConceptScore W162955259C159654299 @default.
• W162955259 hasConceptScore W162955259C163764329 @default.
• W162955259 hasConceptScore W162955259C187212893 @default.
• W162955259 hasConceptScore W162955259C203014093 @default.
• W162955259 hasConceptScore W162955259C2776015282 @default.
• W162955259 hasConceptScore W162955259C2776874634 @default.
• W162955259 hasConceptScore W162955259C2777015399 @default.
• W162955259 hasConceptScore W162955259C2779134260 @default.
• W162955259 hasConceptScore W162955259C2780022809 @default.
• W162955259 hasConceptScore W162955259C63363279 @default.
• W162955259 hasConceptScore W162955259C71924100 @default.
• W162955259 hasConceptScore W162955259C90924648 @default.
• W162955259 hasIssue "8" @default.
• W162955259 hasLocation W1629552591 @default.
• W162955259 hasOpenAccess W162955259 @default.
• W162955259 hasPrimaryLocation W1629552591 @default.
• W162955259 hasRelatedWork W165669756 @default.
• W162955259 hasRelatedWork W1977645254 @default.
• W162955259 hasRelatedWork W2062030308 @default.
• W162955259 hasRelatedWork W2074986892 @default.
• W162955259 hasRelatedWork W2125615840 @default.
• W162955259 hasRelatedWork W2156299866 @default.
• W162955259 hasRelatedWork W2319931263 @default.
• W162955259 hasRelatedWork W2412099477 @default.
• W162955259 hasRelatedWork W32539372 @default.
• W162955259 hasRelatedWork W2502283878 @default.
• W162955259 hasVolume "42" @default.
• W162955259 isParatext "false" @default.
• W162955259 isRetracted "false" @default.
• W162955259 magId "162955259" @default.
• W162955259 workType "article" @default.